Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases
J-Q Mi(Shanghai Jiao Tong University), L-Y Ma(Shanghai Jiao Tong University), Yu Yao(Qinghai University), Zhiao Chen(Shanghai Jiao Tong University), Chen Fy(Shanghai Jiao Tong University), X-X Jiang(Shanghai Jiao Tong University), Xiang Wang(Peking University), Jinhui Wang(Sun Yat-sen University), Bin Chen(Shanghai Jiao Tong University), Bo Jiao(Shanghai Jiao Tong University), S-G Hao(Shanghai Jiao Tong University), J-F Zhou(Shanghai Jiao Tong University), S-M Xiong(Shanghai Jiao Tong University), J-Y Tang(Shanghai Jiao Tong University), Z-X Shen(Shanghai Jiao Tong University), S-H Shen(Shanghai Jiao Tong University), L-J Gu(Shanghai Jiao Tong University), Hui Jiang(Shanghai Jiao Tong University), H-J Lu(Shanghai Jiao Tong University)
Cited by 72
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|JAMA Oncology|2020|245
Temozolomide-associated hypermutation in gliomas
|Neuro-Oncology|2018|227